2 reports of this reaction
1.7% of all CHEWABLE ASPIRIN reports
#14 most reported adverse reaction
INTENTIONAL PRODUCT MISUSE is the #14 most commonly reported adverse reaction for CHEWABLE ASPIRIN, manufactured by Chain Drug Marketing Association, Inc.. There are 2 FDA adverse event reports linking CHEWABLE ASPIRIN to INTENTIONAL PRODUCT MISUSE. This represents approximately 1.7% of all 121 adverse event reports for this drug.
Patients taking CHEWABLE ASPIRIN who experience intentional product misuse should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTENTIONAL PRODUCT MISUSE is a less commonly reported adverse event for CHEWABLE ASPIRIN, but still significant enough to appear in the safety profile.
In addition to intentional product misuse, the following adverse reactions have been reported for CHEWABLE ASPIRIN:
The following drugs have also been linked to intentional product misuse in FDA adverse event reports:
INTENTIONAL PRODUCT MISUSE has been reported as an adverse event in 2 FDA reports for CHEWABLE ASPIRIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
INTENTIONAL PRODUCT MISUSE accounts for approximately 1.7% of all adverse event reports for CHEWABLE ASPIRIN, making it a notable side effect.
If you experience intentional product misuse while taking CHEWABLE ASPIRIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.